GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Avricore Health Inc (TSXV:AVCR) » Definitions » Cyclically Adjusted PB Ratio

Avricore Health (TSXV:AVCR) Cyclically Adjusted PB Ratio : 0.75 (As of Jun. 03, 2025)


View and export this data going back to 2001. Start your Free Trial

What is Avricore Health Cyclically Adjusted PB Ratio?

As of today (2025-06-03), Avricore Health's current share price is C$0.06. Avricore Health's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2024 was C$0.08. Avricore Health's Cyclically Adjusted PB Ratio for today is 0.75.

The historical rank and industry rank for Avricore Health's Cyclically Adjusted PB Ratio or its related term are showing as below:

TSXV:AVCR' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.25   Med: 1.53   Max: 17.5
Current: 0.71

During the past years, Avricore Health's highest Cyclically Adjusted PB Ratio was 17.50. The lowest was 0.25. And the median was 1.53.

TSXV:AVCR's Cyclically Adjusted PB Ratio is ranked better than
73.91% of 138 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.885 vs TSXV:AVCR: 0.71

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Avricore Health's adjusted book value per share data for the three months ended in Dec. 2024 was C$0.019. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is C$0.08 for the trailing ten years ended in Dec. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Avricore Health Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Avricore Health's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avricore Health Cyclically Adjusted PB Ratio Chart

Avricore Health Annual Data
Trend Jun15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 4.59 3.55 1.98 0.71

Avricore Health Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.98 1.50 2.00 2.22 0.71

Competitive Comparison of Avricore Health's Cyclically Adjusted PB Ratio

For the Diagnostics & Research subindustry, Avricore Health's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avricore Health's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Avricore Health's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Avricore Health's Cyclically Adjusted PB Ratio falls into.


;
;

Avricore Health Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Avricore Health's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.06/0.08
=0.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avricore Health's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2024 is calculated as:

For example, Avricore Health's adjusted Book Value per Share data for the three months ended in Dec. 2024 was:

Adj_Book=Book Value per Share/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0.019/127.3637*127.3637
=0.019

Current CPI (Dec. 2024) = 127.3637.

Avricore Health Quarterly Data

Book Value per Share CPI Adj_Book
201503 0.267 99.789 0.341
201506 0.243 100.500 0.308
201509 0.235 100.421 0.298
201512 0.227 99.947 0.289
201603 0.230 101.054 0.290
201606 0.215 102.002 0.268
201609 0.000 101.765 0.000
201612 0.128 101.449 0.161
201703 0.087 102.634 0.108
201706 0.080 103.029 0.099
201709 0.062 103.345 0.076
201712 0.090 103.345 0.111
201803 0.076 105.004 0.092
201806 0.082 105.557 0.099
201809 0.067 105.636 0.081
201812 0.022 105.399 0.027
201903 0.014 106.979 0.017
201906 0.003 107.690 0.004
201909 -0.004 107.611 -0.005
201912 -0.009 107.769 -0.011
202003 -0.011 107.927 -0.013
202006 -0.015 108.401 -0.018
202009 -0.014 108.164 -0.016
202012 -0.010 108.559 -0.012
202103 0.027 110.298 0.031
202106 0.025 111.720 0.029
202109 0.024 112.905 0.027
202112 0.023 113.774 0.026
202203 0.021 117.646 0.023
202206 0.019 120.806 0.020
202209 0.018 120.648 0.019
202212 0.020 120.964 0.021
202303 0.000 122.702 0.000
202306 0.018 124.203 0.018
202309 0.018 125.230 0.018
202312 0.020 125.072 0.020
202403 0.022 126.258 0.022
202406 0.023 127.522 0.023
202409 0.025 127.285 0.025
202412 0.019 127.364 0.019

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Avricore Health  (TSXV:AVCR) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Avricore Health Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Avricore Health's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Avricore Health Business Description

Traded in Other Exchanges
Address
1120 - 789 West Pender Street, Vancouver, BC, CAN, V6C 1H2
Avricore Health Inc is a Canada-based company. The company is involved in the business of health data and point-of-care technologies. The Company has only one segment, being the HealthTab - Point of Care Business in Canada. The Company's revenues are generated from operating leases of the POCT system and the sale of testing panels.
Executives
Kiriaki Smith Senior Officer
Rodger Mckendry Seccombe Senior Officer
Alan Arnstein Director
David Farnfield Director
David M. Hall Director
Inc. Emerald Health Therapeutics 10% Security Holder
Sukhwinder Singh Rai Director

Avricore Health Headlines

No Headlines